Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)

Clinical trial NCT01019928 · COMPLETED

Trial details

NCT number: NCT01019928
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sensitivity in Esophagus

Start date: 2009-11-01
Primary completion: 2011-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.